Nestlé S.A. (FRA:NESM)

Inozyme Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	196,862	205,228	271,143	299,190	338,095	268,298
Market Cap Growth	-11.35%	-24.31%	-9.37%	-11.51%	26.02%	-3.62%
Enterprise Value	261,768	269,352	331,242	348,313	375,953	299,698
Last Close Price	76.00	78.09	99.24	102.18	112.05	85.96
PE Ratio	17.84	17.69	22.52	31.90	20.74	23.74
PS Ratio	2.02	2.10	2.70	3.12	4.01	3.43
PB Ratio	6.33	5.25	6.94	6.91	6.52	6.24
P/FCF Ratio	19.68	17.45	24.68	43.40	39.02	28.19
P/OCF Ratio	12.61	11.55	15.83	24.83	25.28	20.20
EV/Sales Ratio	2.68	2.76	3.30	3.63	4.46	3.83
EV/EBITDA Ratio	12.52	13.90	16.98	18.87	22.73	19.28
EV/EBIT Ratio	15.08	16.23	19.69	22.00	26.62	22.71
EV/FCF Ratio	26.17	22.90	30.15	50.53	43.39	31.49
Debt / Equity Ratio	2.26	1.73	1.52	1.27	0.87	0.86
Debt / EBITDA Ratio	3.60	3.37	2.94	2.88	2.63	2.29
Debt / FCF Ratio	7.02	5.76	5.40	7.97	5.22	3.89
Asset Turnover	0.68	0.69	0.71	0.69	0.67	0.67
Inventory Turnover	3.52	3.87	3.74	3.83	4.12	4.42
Quick Ratio	0.37	0.48	0.49	0.48	0.66	0.51
Current Ratio	0.71	0.82	0.83	0.88	0.98	0.86
Return on Equity (ROE)	33.76%	30.58%	29.07%	19.88%	34.31%	24.90%
Return on Assets (ROA)	7.02%	7.32%	7.48%	7.13%	6.95%	7.09%
Return on Capital (ROIC)	9.61%	10.14%	10.37%	9.89%	9.78%	10.10%
Return on Capital Employed (ROCE)	17.90%	16.20%	17.50%	16.40%	14.80%	16.90%
Earnings Yield	5.60%	5.65%	4.44%	3.14%	4.82%	4.21%
FCF Yield	5.08%	5.73%	4.05%	2.30%	2.56%	3.55%
Dividend Yield	3.47%	4.16%	3.25%	2.92%	2.41%	2.96%
Payout Ratio	76.17%	71.81%	69.85%	82.18%	45.44%	62.95%
Buyback Yield / Dilution	1.65%	1.85%	2.25%	2.94%	2.04%	2.90%
Total Shareholder Return	5.12%	6.01%	5.50%	5.86%	4.45%	5.85%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.